GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 30, 2026
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GlaxoSmithKline Pharmaceuticals has informed the stock exchange about its upcoming Annual General Meeting scheduled for June 30, 2026. This is a routine regulatory disclosure required of all listed companies ahead of their AGM. The detailed notice containing the meeting agenda, financial statements, and any proposed resolutions will be sent separately to shareholders. The AGM is where shareholders vote on key matters such as approval of accounts, director appointments, auditor ratification, and dividend declarations.
No immediate impact on the stock price as this is a standard procedural filing. Investors should watch for the actual AGM notice containing agenda items, particularly any proposals on dividends, board changes, or special business.